Search This Blog

Wednesday, August 1, 2018

Theravance Biopharma reports Q2 EPS (76c), consensus ($1.20)


Reports Q2 revenue $23.5M, consensus $10.67M. 
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)